The Impact of Sinopharm COVID-19 Vaccination on Male Fertility of the Egyptian Population

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic Test
Study Type: Observational
SUMMARY

The investigators shall study the effect of Sinopharm vaccination on semen parameters and serum testosterone

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Receiving Sinopharm COVID-19 vaccines Male age 18-50 years old

Locations
Other Locations
Egypt
Faculty of Medicine, Cairo University
Recruiting
Cairo
Contact Information
Primary
Mohamed Tarek H Anis, M.D.
tarekanis@kasralainy.edu.eg
+201222163858
Backup
Islam Fathy, M.D.
islamandrology@yahoo.com
+201004244360
Time Frame
Start Date: July 3, 2021
Estimated Completion Date: August 30, 2022
Participants
Target number of participants: 100
Treatments
Sinopharm vaccine group
Participants scheduled to receive the Sinopharm vaccine will be evaluated on its effect on semen parameters for up to 6 months post vaccination.
Authors
Mohamed Tarek H Anis
Sponsors
Leads: Cairo University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials